about
The etiologic spectrum of head and neck squamous cell carcinoma in young patientsImpaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse?Tumors as organs: complex tissues that interface with the entire organismStimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinomaExpression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas.Transgenic expression of P1A induced thymic tumor: a role for onco-fetal antigens in tumorigenesis.Histologic and systemic prognosticators for local control and survival in margin-negative transoral laser microsurgery treated oral cavity squamous cell carcinoma.Evolution of T-cell clonality in a patient with Ph-negative acute lymphocytic leukemia occurring after interferon and imatinib therapy for Ph-positive chronic myeloid leukemia.Decreased level of recent thymic emigrants in CD4+ and CD8+T cells from CML patientsA cytokine-mediated link between innate immunity, inflammation, and cancer.Systemic zinc redistribution and dyshomeostasis in cancer cachexia.A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk.Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro-esophageal junction.Thymosin-alpha1 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes.Radiation, inflammation, and immune responses in cancerEffects of a Shuangling Fuzheng anticancer preparation on the proliferation of SGC-7901 cells and immune function in a cyclophosphamide-treated murine model.Community of protein complexes impacts disease association.Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci.Rebuilding immunity in cancer patients.The Immunoregulatory Potential of Particle Radiation in Cancer Therapy.Advances and applications of molecular cloning in clinical microbiology.The potential role of immunotherapy to treat colorectal cancer.A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects.Monocyte chemoattractant protein 1 (MCP-1/CCL2) contributes to thymus atrophy in acute myeloid leukemia.Enhanced T cell immunity by B7-H4 downregulation in nonsmall-cell lung cancer cell lines.Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity.Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia.Immunotherapy of head and neck cancer: current and future considerations.The relationship between KRAS gene mutations and HLA class I antigen downregulation in the metastasis of non-small cell lung cancer.Ethanol suppression of the hypothalamic proopiomelanocortin level and the splenic NK cell cytolytic activity is associated with a reduction in the expression of proinflammatory cytokines but not anti-inflammatory cytokines in neuroendocrine and immuChange in expression pattern of TCR-CD3 complex in patients with multiple myeloma.Amelioration of doxorubicin-induced myocardial oxidative stress and immunosuppression by grape seed proanthocyanidins in tumour-bearing mice.Plasmacytoid dendritic cells (PDC) are the major DC subset innately producing cytokines in human lymph nodes.Antioxidant and Anticoagulant Status Were Improved by Personalized Dietary Intervention Based on Biochemical and Clinical Parameters in Cancer Patients.Does caffeine reverse the EAC cell-induced immune suppression?A novel mechanism of tumor-induced thymic atrophy in mice bearing H22 hepatocellular carcinoma.Dietary zinc intake and brain cancer in adults: a case-control study.Imbalances in circulating lymphocyte subsets in Hu antibody associated paraneoplastic neurological syndromesBacterial Translocation Is Reduced by a Specific Nutritional Combination in Mice with Chemotherapy-Induced Neutropenia
P2860
Q26741362-0CB74DAF-4A5B-4FEB-BEF3-D4C7405D80F8Q27003955-7336EEDF-6FBB-489A-B095-8C41A35D380AQ30495528-CF031D78-1FF3-4460-85DF-F093817F76E0Q33317415-A0078411-7446-4A9B-8C27-C344C0392069Q33325701-6254354E-67FA-4AF4-9701-22C4F9D04D69Q33728430-AE78502F-5063-4EE5-97A1-BC05B6F5ADA3Q33740789-D495B46C-E963-483C-ADA9-EF161AF23D49Q33809446-99C7F3A7-F4F0-43EC-B73A-D6BD196D7111Q33891337-754143B6-B263-42A9-85F3-6503EB911106Q34625152-CC7475D8-691B-4E83-8BB4-7191AD2E8FC5Q34697225-A60C7229-35FC-4611-A7BB-0001EDAF3E28Q35474078-A03EDE50-93A5-447E-B5B0-E00471A0E4BEQ35617680-7ABEE8F2-E86D-4E62-A8E8-A87597D4729BQ36003011-7E6A5FE4-84CA-49F4-B67E-78E113D8148BQ36005646-C297EAC4-A4CA-4C56-83B3-F06BBB02356CQ36178217-E66ED569-A534-4780-8670-73DFC000222BQ36333988-8901EE1C-2532-4EBF-92E6-4A84D8653241Q36906789-6815E1CF-6C44-40DD-A7D1-6632C9AF8F0FQ36934947-69689CCB-90AD-4CA0-B8BB-701BFD175BD4Q37625801-03E6DB95-182F-4287-B9B6-37DB9A3FFBF2Q38229428-881C54C3-64A3-4A2E-A87A-7EFFDD8A2FBFQ38292169-E6D81A83-E6DD-4AA3-861E-DCE56DFEE085Q38842975-367B76F5-47B0-4208-83DC-88842CFFC10FQ39100783-F5F36347-1CBC-4F55-A8C1-C61F41C1C8A2Q39345115-602B4A5A-EA11-4617-9A08-740CC3AF2270Q39529481-78F9EE1A-6070-46C6-8648-5308B3068763Q39914874-CAE4778E-D80D-4240-A481-C65CD7EF78F2Q39955461-6C8D28CD-64D0-4EDF-B99A-89E2A0DF785BQ42274351-FC1188DA-9E01-45FA-BDFB-A4A3D0A3EDB7Q42503288-E4F11604-5BBC-47F4-9F93-3B32D371A2CBQ46002196-77796CB1-A018-4E90-800C-45C1A1975173Q46651853-9A67D03C-176A-4222-8C97-AD2E26CED642Q46783971-8D1C9B4A-F4AD-4A92-B246-2AA41206AC91Q51336591-DD76D450-0091-47D3-B229-0D4059AB9F92Q51745868-AAC34720-AA2C-4DDE-B15A-46B500AE301FQ52649899-9540D61C-4C30-4147-86C1-4B2BB33C0FC4Q55467720-06184985-7428-4523-9FFE-0ED956091FCCQ56961954-3D602029-2EAE-45A7-AEF6-64E09AAE9B63Q57984333-241FF602-1AF6-4C6C-B5B5-7593681B7B3B
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Immunodeficiency and cancer: prospects for correction.
@ast
Immunodeficiency and cancer: prospects for correction.
@en
type
label
Immunodeficiency and cancer: prospects for correction.
@ast
Immunodeficiency and cancer: prospects for correction.
@en
prefLabel
Immunodeficiency and cancer: prospects for correction.
@ast
Immunodeficiency and cancer: prospects for correction.
@en
P1476
Immunodeficiency and cancer: prospects for correction.
@en
P2093
John W Hadden
P304
P356
10.1016/S1567-5769(03)00060-2
P577
2003-08-01T00:00:00Z